FARN — Faron Pharmaceuticals Oy Share News
0.000.00%
Last trade - 00:00
- £91.81m
- £97.16m
REG - Faron Pharma. Oy - Title: BEXMAB study update
AnnouncementREG - Faron Pharma. Oy - Faron’s Financial Calendar for 2023
AnnouncementREG - Faron Pharma. Oy - BEXMAB Study Update
AnnouncementREG - Faron Pharma. Oy - Faron Appoints Maija Hollmén PhD as CSO
AnnouncementREG - Faron Pharma. Oy - Amendment Terms and Conditions with IPF Partners
AnnouncementRCS - Faron Pharma. Oy - Faron Announces Poster Presentation at SITC
AnnouncementREG - Faron Pharma. Oy - BEXMAB Study Update
AnnouncementREG - Faron Pharma. Oy - Holding(s) in Company
AnnouncementREG - Faron Pharma. Oy - Holding(s) in Company
AnnouncementRCS - Faron Pharma. Oy - Faron Announces Melanoma Cohort Data from MATINS
AnnouncementREG - Faron Pharma. Oy - Results of Placing
AnnouncementREG - Faron Pharma. Oy - Proposed Issue and Placing of Shares
AnnouncementREG - Faron Pharma. Oy - Grant of Options
AnnouncementREG - Faron Pharma. Oy - Top-Line Data on Bexmarilimab Dose Variation
AnnouncementRCS - Faron Pharma. Oy - Faron to Host Bexmarilimab Update Webcast
AnnouncementRCS - Faron Pharma. Oy - Traumakine Data Presented at MHSR Symposium
AnnouncementRCS - Faron Pharma. Oy - Faron to Present at Upcoming Conferences
AnnouncementREG - Faron Pharma. Oy - Faron Reports 2022 Half-Year Financial Results
AnnouncementREG - Faron Pharma. Oy - Notice of Half-Year Financial Results
Announcement